8-K
MILESTONE SCIENTIFIC INC. (MLSS)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Dateof Report (Date of earliest event reported): November 7, 2025
MilestoneScientific Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-14053 | 13-3545623 |
|---|---|---|
| (State<br> or other jurisdiction<br><br> <br>of<br> incorporation) | (Commission<br><br> <br>File<br> Number) | (IRS<br> Employer<br><br> <br>Identification<br> No.) |
| 425 Eagle Rock Avenue<br><br> <br>Suite 403<br><br> <br>Roseland, New Jersey <br><br> (Address of principal executive offices) | 07068<br><br> <br>(Zip<br> Code) | |
| --- | --- |
Registrant’s
telephone number, including area code (973) 535-2717
(Former name or former address, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
| Title<br> of each class | Trading<br> Symbol(s) | Name<br> on exchange on which registered |
|---|---|---|
| Common<br> Stock | MLSS | NYSE<br> American |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
| ☐ | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Item5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangementsof Certain Officers
On November 7, 2025, Mr. Leonard A. Osser, a director of Milestone Scientific Inc., resigned as a director of the company, effective immediately. Mr. Osser wrote that it was an appropriate time to relinquish his director position. Mr. Osser, however, will continue to be involved with the company through his employment agreement and through the consulting agreement between the company and U.S. Asian Consulting Group, LLC.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Milestone Scientific Inc. | ||
|---|---|---|
| Dated:<br> November 13, 2025 | By: | /S/ Eric Hines |
| Eric<br> Hines | ||
| Chief<br> Executive Officer |